Axion Biosystems raising $3.5M
ATLANTA, GA - Axion BioSystems Inc. has raised $3.2 million — part of a $3.5 million planned round, according to a Securities & Exchange Commission filing. The VentureLab graduate is commercializing technology that will allow scientists to evaluate the electrophysiology of neural cells and cardiac cells. Axion develops and sells life science instrumentation. The company’s product, which includes an electronic device integrated with microelectrodes, improves the drug screening process by rapidly extracting valuable information from more complex tissues and cultures,...
Read MoreMichael J. Fox Foundation Expands Funding to Envoy
JUPITER, FL.- Envoy Therapeutics, Inc., a drug discovery company, today announced that it has been awarded a second grant from The Michael J. Fox Foundation (MJFF). The additional funding will enable the continued development of compounds that selectively act on the motor circuitry that is compromised in Parkinson’s disease (PD) via modulation of a receptor target identified by Envoy. Further validation of the functional role of this biological target is intended to pave the way for the progression of compounds through preclinical development and eventually to improved treatment options...
Read MoreArgos Therapeutics Secures $25M Series D Financing
DURHAM, NC– Argos Therapeutics Inc. today announced that it has secured a $25 million Series D financing to support the commencement of its Phase 3 ADAPT study in patients with newly diagnosed, metastatic renal cell carcinoma (mRCC) in mid-2012. The financing was led by Forbion Capital and included other existing investors, including TVM Capital, Lumira Capital, Intersouth Partners, Caisse de dépôt et placement du Québec, Morningside Group, and Aurora Funds. Argos´s Arcelis™ immunotherapy, AGS-003, has also been granted Fast Track designation by the U.S. Food and Drug Administration...
Read MoreMedical Device firm, Elekta, relocating HQ to Dunwoody, Georgia; adds 100 jobs
ATLANTA, GA – The developer of Leksell Gamma Knife, a popular brain cancer treatment device, will add 100 jobs and relocate its North American headquarters from Norcross to The Terraces in Central Perimeter. The Stockholm-based medical device company, Elekta Inc., will locate the new headquarters in about 50,000 square feet atThe Terraces office complex in Atlanta’s Central Perimeter business district. The company could take an additional 20,000 square feet for a training center, sources said. The Elekta relocation and expansion was referred to as “Project Sack” in economic...
Read MoreMedical device company raises $625K
RALEIGH, NC – Medical device company Corinthian Ophthalmic Inc. has raised $625,000 in equity, according to securities filings. But the company still has a long way to go to reach its goal of raising $4 million by the end of May. “We’re looking to get this closed as soon as possible,” says President Skip Ballou. The money will be used for a new device that Ballou hopes could replace the...
Read MoreBaxter International Selects Georgia for $1 Billion Bio-Pharmaceutical Manufacturing Investment
ATLANTA, GA - Gov. Nathan Deal today announced that Baxter International will locate a new bio-pharmaceutical manufacturing facility near Interstate 20 east of Atlanta as well as plasma centers throughout Georgia that will employ approximately 1,500 people across the state with the potential for hundreds more. Total investment by the company will exceed $1 billion. “Baxter’s decision to come to Georgia marks a new era in the growth of our biosciences industry and will have far-reaching impact on our economy,” said Deal. “We are honored to welcome this flagship company to Georgia and...
Read More
Follow Us!